The present study aims to identify patients affected by maternal-fetal alloimmunization in Finland, to characterize pregnancy outcomes, perinatal treatment pattern and long-term outcomes in livebirths to understand their current unmet needs in this patient group. Another aim is to identify predictive risk factors for index and subsequent pregnancies, which may contribute to developing better prognostic tools and prevention measures.
